Merck’s Four-Week Hepatitis C Regimen Fails to Beat Gilead (2)
Alert: HALISTER Source: BN (Bloomberg News)
Tickers GILD US (Gilead Sciences Inc) MRK US (Merck & Co Inc)
People Brian Abrahams (Wachovia Securities Inc) Eliav Barr (Merck & Co Inc) Vamil Divan (Credit Suisse Holdings USA Inc)
Topics Viral Hepatitis Infectious Diseases
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283